| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.0M | — |
| R&D Expense | $16.3M | +44.0% |
| SG&A Expense | $13.7M | +20.3% |
| Operating Income | -$30.0M | -32.1% |
| Pre-tax Income | -$29.4M | -35.8% |
| Income Tax | $38K | -8.1% |
| Net Income | -$29.4M | -36.2% |
| EPS (Basic) | -$0.89 | -17.1% |
| EPS (Diluted) | -$0.89 | -17.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.9M | +431.2% |
| Short-term Investments | $6.5M | — |
| Current Assets | $101.2M | +401.2% |
| Total Assets | $104.8M | +356.9% |
| Current Liabilities | $10.1M | +16.4% |
| Total Liabilities | $11.0M | +13.9% |
| Stockholders' Equity | $93.8M | +607.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.9M | -64.0% |
| Capital Expenditures | $733K | -37.8% |
| Investing Cash Flow | -$7.2M | -512.5% |
| Financing Cash Flow | $107.4M | +573.3% |
| Free Cash Flow | -$24.7M | -56.4% |